---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "Tca/JRT8W701LRBeiB/MLcd9I8aH5WVkjks8N8yZ6wmWb/XQxC+kaMGinPiaqMv6+FH9118EdSXJR1Ll6qbvoAPqg3pXka1bNOmqcn389wJMudnXcOzAMUC6bq/JMHCBueXcpHX101wXNye1riNkom+5BMT8Ytfiw9w4jsKoUvcYuyeASlJWCgjdlveseb2K+4TGT9OThlfqh1ZB9UO101UYdDF+WDJIG+3BLDCGL08s68S+x/YieljrT6MJhP8bp5ck8cuBXZVAN6Ft+pnQoogyiRh1oewJm1jQi7oV8lc308HP1otnW84KjOPXNdkiAvy4JssE0MnMpp662kNSSxssw72TXpoZ3GFHq9UYpKI=;xlLLzmFxDiSVFzpRO9Wuhg=="
---

